Botanix Pharmaceuticals Share Price and Company Fundamentals
Last traded: Today at 6:10 AM
Botanix Pharmaceuticals Limited, a pharmaceutical company, engages in the research and commercialization of solutions for skin diseases and infections in Australia and the United States. The company's lead product is Sofdra (sofpironium) topical gel, a prescription anticholinergic medicine used to treat underarm sweating in adults and children 9 years of age and older. It also develops BTX 1503, a transdermal gel formulation, which is in Phase 3 clinical trial for the treatment of serious acne in adults and teenagers; BTX 1702 that is in Phase 1b/2 clinical trial to treat papulopustular rosacea; BTX 1204A for treating atopic dermatitis; and BTX 1801, which has been completed Phase 2a clinical trial for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus. The company was incorporated in 1984 and is based in Melbourne, Australia.
Key Metrics
PE ratio
-
PB ratio
0.83
Dividend yield
-
Beta
0.86
Market cap
$52.00M
Enterprise value
$19.02M
Company profile
| Industry / Sector | Biotechnology / Healthcare |
|---|---|
| Website | https://www.botanixpharma.com |
| Mailing address | Tower 5, Collins Square Level 23 727 Collins Street Melbourne VIC 3008 Australia |
| Phone / Fax | 61 8 6555 2945 / |
Dividends
More: Botanix Pharmaceuticals Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Botanix Pharmaceuticals paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.BOT dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Sep 2026, following are the company executives and directors listed on Botanix Pharmaceuticals.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Vincent P. Ippolito | Executive Chairman | 66 | |
| Dr. Howie McKibbon | Chief Executive Officer | ||
| Mr. Graeme Morissey | Chief Financial Officer | ||
| Mr. Chris Lesovitz | Chief Financial Officer of United States of America | ||
| Mr. Paul Seaback | Chief Operating Officer | ||
| Dr. Boris Meyerson Ph.D. | Chief Business Officer | ||
| Mr. David Morgan | Head of Corporate Affairs | ||
| Mr. Andrew Bickley | Company Secretary | ||
| Mr. Darin Van Arsdale | Director of Sales Operations |
Profitability and management effectiveness
Profit margin
-206.41%
Operating margin
-206.36%
Return on assets
-36.86%
Return on equity
-96.35%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Botanix Pharmaceuticals is 52.00M and its enterprise value is 19.02M. The enterprise value to revenue ratio of BOT is 0.56. The enterprise value to EBITDA ratio of BOT is -0.28.
The BOT's stocks Beta value is 0.86 making it 14% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Botanix Pharmaceuticals (BOT)
Botanix Pharmaceuticals (ASX:BOT) Frequently Asked Questions
1. What is Botanix Pharmaceuticals's Stock Symbol?
Botanix Pharmaceuticals trades on ASX under the ticker symbol "BOT".
2. What is Botanix Pharmaceuticals's stock price today?
One share of BOT stock can currently be purchased for approximately $0.019.
3. How can I contact Botanix Pharmaceuticals?
Botanix Pharmaceuticals's mailing address is Tower 5, Collins Square Level 23 727 Collins Street Melbourne VIC 3008 Australia. The company can be reached via phone at 61 8 6555 2945.
4. What is Botanix Pharmaceuticals's official website?
The official website of Botanix Pharmaceuticals is https://www.botanixpharma.com.